FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  LOBELL J JAY
 2. Date of Event Requiring Statement (Month/Day/Year)
09/13/2011		 3. Issuer Name and Ticker or Trading Symbol
CORONADO BIOSCIENCES INC [NONE]
(Last)
(First)
(Middle)
C/O CORONADO BIOSCIENCES, INC., 15 NEW ENGLAND EXECUTIVE PARK		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

BURLINGTON, MA 01803		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $.001 per share 296,000
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase Common Stock   (1) 10/05/2020 Common Stock 25,000 $ 1.37 D  
Warrant to purchase Common Stock 04/26/2010 01/22/2014 Common Stock 17,878 $ 9.23 I By Paramount Credit Partners, LLC
Warrant to purchase Common Stock 04/26/2010 05/28/2014 Common Stock 3,337 $ 9.23 I By Paramount Credit Partners, LLC
Warrant to purchase Common Stock 04/26/2010 06/25/2014 Common Stock 5,960 $ 9.23 I By Paramount Credit Partners, LLC

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
LOBELL J JAY
C/O CORONADO BIOSCIENCES, INC.
15 NEW ENGLAND EXECUTIVE PARK
BURLINGTON, MA 01803		   X      

Signatures

By: /s/ J. Jay Lobell 09/13/2011
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) One-third of the shares will vest on each of October 5, 2011, 2012 and 2013.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.